216 related articles for article (PubMed ID: 30854398)
21. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.
Tehrani FR; Rashidi H; Azizi F
Reprod Biol Endocrinol; 2011 Nov; 9():144. PubMed ID: 22044512
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
23. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
24. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Gabrielli L; de Almeida Mda C; Aquino EM
Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079
[TBL] [Abstract][Full Text] [Related]
25. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran.
Hashemipour M; Faghihimani S; Zolfaghary B; Hovsepian S; Ahmadi F; Haghighi S
Horm Res; 2004; 62(6):278-82. PubMed ID: 15523185
[TBL] [Abstract][Full Text] [Related]
27. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
28. Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up.
Karjula S; Morin-Papunen L; Auvinen J; Ruokonen A; Puukka K; Franks S; Järvelin MR; Tapanainen JS; Jokelainen J; Miettunen J; Piltonen TT
J Clin Endocrinol Metab; 2017 Jun; 102(6):1861-1869. PubMed ID: 28323926
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
[TBL] [Abstract][Full Text] [Related]
30. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
[TBL] [Abstract][Full Text] [Related]
31. Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: A cross-sectional study.
Kim JH; Kim O; Jung H; Pang Y; Dan H
Health Care Women Int; 2022; 43(1-3):85-97. PubMed ID: 34292855
[TBL] [Abstract][Full Text] [Related]
32. Curcumin and Teupolioside attenuate signs and symptoms severity associated to hirsutism in PCOS women: a preliminary pilot study.
Malvasi A; Tinelli A; Dellino M; Trojano G; Vinciguerra M; Mina M
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6187-6191. PubMed ID: 36111918
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women.
Yang JH; Weng SL; Lee CY; Chou SY; Hsu CS; Hsu MI
Arch Gynecol Obstet; 2010 Sep; 282(3):327-33. PubMed ID: 20431891
[TBL] [Abstract][Full Text] [Related]
34. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
Pembe AB; Abeid MS
Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
[TBL] [Abstract][Full Text] [Related]
36. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
37. Female Pelvic Conditions: Polycystic Ovary Syndrome.
Wilkinson LD; Brady PH; Gin GT; Rosenblum E
FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based approach to cutaneous hyperandrogenism in women.
Schmidt TH; Shinkai K
J Am Acad Dermatol; 2015 Oct; 73(4):672-90. PubMed ID: 26138647
[TBL] [Abstract][Full Text] [Related]
39. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
[TBL] [Abstract][Full Text] [Related]
40. Is acne a sign of androgen excess disorder or not?
Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
